Psychemedics (PMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -1,861 | -2,050 | -1,515 | -688 | -4,154 |
| Depreciation Amortization | 2,081 | 1,668 | 1,215 | 551 | 2,670 |
| Income taxes - deferred | N/A | N/A | N/A | N/A | 691 |
| Accounts receivable | 1,187 | 362 | 629 | -196 | 52 |
| Accounts payable and accrued liabilities | -290 | 242 | -90 | 379 | 304 |
| Other Working Capital | -205 | -532 | -637 | -633 | -1,726 |
| Other Operating Activity | 17 | 220 | 45 | 114 | 683 |
| Operating Cash Flow | $929 | $-90 | $-353 | $-473 | $-1,480 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -87 | -30 | -24 | N/A | -159 |
| Purchase Sale Intangibles | N/A | -31 | -23 | -8 | N/A |
| Other Investing Activity | 0 | 64 | 56 | 5 | 0 |
| Investing Cash Flow | $-87 | $34 | $32 | $5 | $-159 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -305 | -495 | -209 | -75 | -294 |
| Common Stock Issued | 1,965 | N/A | N/A | N/A | -54 |
| Common Stock Repurchased | -2,563 | N/A | N/A | N/A | N/A |
| Dividend Paid | N/A | N/A | N/A | N/A | -799 |
| Other Financing Activity | -486 | -8 | 0 | 0 | 0 |
| Financing Cash Flow | $-1,389 | $-503 | $-209 | $-75 | $-1,147 |
| Beginning Cash Position | 1,964 | 1,964 | 1,964 | 1,964 | 4,750 |
| End Cash Position | 1,417 | 1,405 | 1,434 | 1,421 | 1,964 |
| Net Cash Flow | $-547 | $-559 | $-530 | $-543 | $-2,786 |
| Free Cash Flow | |||||
| Operating Cash Flow | 929 | -90 | -353 | -473 | -1,480 |
| Capital Expenditure | -87 | -30 | -24 | N/A | -159 |
| Free Cash Flow | 842 | -120 | -377 | -473 | -1,639 |